Experienced in Thrombocytopenia

Satoshi Hamauchi

Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, 
Shimonagakubo, JP 
Experienced in Thrombocytopenia
Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, 
Shimonagakubo, JP 
OverviewLocationsClinical Research

Overview

Satoshi Hamauchi practices in Shimonagakubo, Japan. Mr. Hamauchi is rated as an Experienced expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Agranulocytosis, Esophageal Cancer, Gastrostomy, and Stent Placement.

His clinical research consists of co-authoring 55 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Thrombocytopenia.

Gender
Male

Locations

Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, Shimonagakubo, 4118777, Japan
Other Locations
Shizuoka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab, Fluorouracil, Cisplatin, Carboplatin
Study Phase: Phase 3

55 Total Publications

Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Journal: International journal of clinical oncology
Published: March 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hamauchi's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile